Faculty, Staff and Student Publications

Language

English

Publication Date

1-1-2024

Journal

Frontiers in Oncology

DOI

10.3389/fonc.2024.1362247

PMID

38500662

PMCID

PMC10944957

PubMedCentral® Posted Date

March 2024

PubMedCentral® Full Text Version

Post-print

Abstract

The transforming growth factor (TGF)-β superfamily has important physiologic roles and is dysregulated in many pathologic processes, including pancreatic cancer. Pancreatic cancer is one of the most lethal cancer diagnoses, and current therapies are largely ineffective due to tumor resistance and late-stage diagnosis with poor prognosis. Recent efforts are focused on the potential of immunotherapies in improving therapeutic results for patients with pancreatic cancer, among which TGF-β has been identified as a promising target. This review focuses on the role of TGF-β in the diseased pancreas and pancreatic cancer. It also aims to summarize the current status of therapies targeting the TGF-β superfamily and postulate potential future directions in targeting the TGF-β signaling pathways.

Keywords

TGF-β, acute pancreatitis, chronic pancreatitis, pancreatic ductal adenocarcinoma, pancreatic stellate cells

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.